DE60222529D1 - Herstellungsverfahren für kombinationsimpfstoffe - Google Patents

Herstellungsverfahren für kombinationsimpfstoffe

Info

Publication number
DE60222529D1
DE60222529D1 DE60222529T DE60222529T DE60222529D1 DE 60222529 D1 DE60222529 D1 DE 60222529D1 DE 60222529 T DE60222529 T DE 60222529T DE 60222529 T DE60222529 T DE 60222529T DE 60222529 D1 DE60222529 D1 DE 60222529D1
Authority
DE
Germany
Prior art keywords
manufacturing process
combination vaccines
vaccines
combination
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60222529T
Other languages
English (en)
Other versions
DE60222529T2 (de
Inventor
Kyu-Wan Kim
Hyi-Jeong Ji
Youn-Kyeong Lee
Wan-Kyu Kim
Hee-Ku Lee
Won-Kyum Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19704448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60222529(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LG Life Sciences Ltd filed Critical LG Life Sciences Ltd
Publication of DE60222529D1 publication Critical patent/DE60222529D1/de
Application granted granted Critical
Publication of DE60222529T2 publication Critical patent/DE60222529T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0017—Combination vaccines based on whole cell diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60222529T 2001-01-10 2002-01-09 Herstellungsverfahren für kombinationsimpfstoffe Revoked DE60222529T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2001-0001290A KR100401423B1 (ko) 2001-01-10 2001-01-10 혼합 백신의 제조 방법
KR2001001290 2001-01-10
PCT/KR2002/000034 WO2002055105A1 (en) 2001-01-10 2002-01-09 Manufacturing method of combined vaccine

Publications (2)

Publication Number Publication Date
DE60222529D1 true DE60222529D1 (de) 2007-10-31
DE60222529T2 DE60222529T2 (de) 2008-06-19

Family

ID=19704448

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222529T Revoked DE60222529T2 (de) 2001-01-10 2002-01-09 Herstellungsverfahren für kombinationsimpfstoffe

Country Status (21)

Country Link
US (2) US20040048336A1 (de)
EP (1) EP1349572B1 (de)
JP (1) JP3977257B2 (de)
KR (1) KR100401423B1 (de)
CN (1) CN1228086C (de)
AR (1) AR032391A1 (de)
AT (1) ATE373485T1 (de)
AU (1) AU2002219693B2 (de)
BR (1) BR0206391A (de)
CA (1) CA2434421C (de)
DE (1) DE60222529T2 (de)
ES (1) ES2291466T3 (de)
IL (1) IL156791A0 (de)
MX (1) MXPA03006154A (de)
MY (1) MY143688A (de)
PE (1) PE20020758A1 (de)
PL (1) PL211005B1 (de)
RU (1) RU2264226C2 (de)
UY (1) UY27118A1 (de)
WO (1) WO2002055105A1 (de)
ZA (1) ZA200305072B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835663B1 (de) 1992-05-23 2009-09-30 GlaxoSmithKline Biologicals S.A. Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
GB0522765D0 (en) 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
CN101460180B (zh) * 2006-05-31 2012-06-27 西尔维奥·布齐 与白喉毒素免疫相关的蛋白质分子的药物应用
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
AU2007293673B2 (en) * 2006-09-07 2013-06-27 Glaxosmithkline Biologicals S.A. Vaccine
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
IT1398927B1 (it) 2009-06-25 2013-03-28 Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
GB0917647D0 (en) 2009-10-08 2009-11-25 Glaxosmithkline Biolog Sa Expression system
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
KR101518473B1 (ko) 2013-03-14 2015-05-07 (주)바이오인디스트 애완견의 바이러스성 전염병 예방 및 치료용 복합 난황 항체 조성물 및 그 제조방법
AR102547A1 (es) * 2014-11-07 2017-03-08 Takeda Vaccines Inc Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
AR102548A1 (es) 2014-11-07 2017-03-08 Takeda Vaccines Inc Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y uso
KR20220076405A (ko) * 2020-11-30 2022-06-08 주식회사 엘지화학 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
DE3788902T3 (de) * 1986-06-17 2004-11-25 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Hepatitis-Delta-Diagnostika und Impfstoffe, ihre Herstellung und Verwendung.
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
EP0835663B1 (de) * 1992-05-23 2009-09-30 GlaxoSmithKline Biologicals S.A. Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
DE69731357T2 (de) * 1996-03-23 2006-02-02 The Research Foundation For Microbial Diseases Of Osaka University, Suita Funktionelles antigenfragment von tetanustoxin und tetanusvakzine
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
EP1762246A1 (de) * 1996-07-02 2007-03-14 Sanofi Pasteur Limited Vielwertige DTP-Polio-Impfstoffe
GB9623233D0 (en) * 1996-11-07 1997-01-08 Smithkline Beecham Biolog Vaccine composition
CA2303105A1 (en) * 1997-09-15 1999-03-25 Pasteur Merieux Msd Multivalent vaccines
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
US20090181050A1 (en) 2009-07-16
ZA200305072B (en) 2003-09-17
AU2002219693B2 (en) 2006-03-16
ATE373485T1 (de) 2007-10-15
BR0206391A (pt) 2004-07-27
JP3977257B2 (ja) 2007-09-19
US20040048336A1 (en) 2004-03-11
PE20020758A1 (es) 2002-08-29
PL369433A1 (en) 2005-04-18
CN1484531A (zh) 2004-03-24
KR20020060298A (ko) 2002-07-18
WO2002055105A1 (en) 2002-07-18
CA2434421A1 (en) 2002-07-18
CA2434421C (en) 2012-02-21
UY27118A1 (es) 2002-08-30
MXPA03006154A (es) 2003-09-16
KR100401423B1 (ko) 2003-10-17
EP1349572B1 (de) 2007-09-19
CN1228086C (zh) 2005-11-23
IL156791A0 (en) 2004-02-08
AR032391A1 (es) 2003-11-05
RU2264226C2 (ru) 2005-11-20
DE60222529T2 (de) 2008-06-19
PL211005B1 (pl) 2012-03-30
MY143688A (en) 2011-06-30
EP1349572A1 (de) 2003-10-08
JP2004517866A (ja) 2004-06-17
EP1349572A4 (de) 2004-09-15
RU2003124660A (ru) 2005-01-10
ES2291466T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
DE50110649D1 (de) Zubereitung für restenoseprophylaxe
DE60205413D1 (de) Herstellungsverfahren
DE60232513D1 (de) Verbessertes zunderkonditionierverfahren
DE60336429D1 (de) HERSTELLUNGSVERFAHREN FÜR Ta-SPUTTERTARGET
DE60235253D1 (de) Herstellungsverfahren für katalysatorelement
DE60216133D1 (de) Reifenherstellungsverfahren
DE60226131D1 (de) Strickverfahren
DE60222529D1 (de) Herstellungsverfahren für kombinationsimpfstoffe
DE60211934D1 (de) Kupplung für rückhalterung
ATE360674T1 (de) Hydrierverfahren
DE60233109D1 (de) Radidentifikator- ortungsverfahren
NO20022644D0 (no) Renseprosess
DE60115364D1 (de) Herstellungsverfahren für stranggussknüppel
ATE427957T1 (de) Echinocandinverfahren
DE60225255D1 (de) Fadenführer für strick- oder kulierwirkmaschine
DE60130426D1 (de) Aluminiumoxid-Leuchtstoff- Herstellungsverfahren
DE60235943D1 (de) Stahlherstellungsverfahren
ITMI20021031A0 (it) Procedimento per preparare policarbonato-polioli
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE60207451D1 (de) Produktionsverfahren
DE50115802D1 (de) Dafür
ITMI20020240A1 (it) Metodo per fabbricare un oggetto ornamentale
NO20022643D0 (no) Reduksjonsprosess
FI20011146A0 (fi) Uusi valmistusmenetelmä
SE0101979D0 (sv) New Process

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: GRUENECKER, KINKELDEY, STOCKMAIR & SCHWANHAEUSSER,

8331 Complete revocation